While this phenotype is similar to that seen in APL, the characteristic features, including higher levels of CD15 and CD64, frequent HLA-DR expression, and low to absent myeloperoxidase, in the blast equivalents [25,31,82] generally differentiate AML with KMT2A rearrangement from APL. This evidence concerns the gene FCGR1A and acute myeloid leukemia.